← Eichor
Study identifier: NCT07509359 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children

Condition: Vascular Access Device Complications  ·  Sponsor: Seoul National University Hospital

PhaseNA
Planned participants96
Who can joinAll sexes, 2 Years to 17 Years
Healthy volunteersYes

About this study

This prospective randomized controlled trial aims to compare basilic vein and cephalic vein approaches for midline catheter placement in pediatric patients undergoing general anesthesia. Participants aged 2 to 17 years who require midline catheter insertion will be randomly assigned 1:1 to either the basilic vein group or the cephalic vein group. The primary outcome is the clinical blood sampling success rate during the catheter dwell period, defined as successful aspiration of ≥2 mL of blood through the midline catheter at least once without additional venipuncture. Secondary outcomes include operator-rated difficulty, number of puncture attempts, first attempt cannulation success rate, vein diameter and depth, catheter dwell time, catheter-related complications, and patient satisfaction. A total of 96 participants (48 per arm) will be enrolled at Seoul National University Children's Hospital.

This description comes directly from the study's public registry record.

Talk to the study team

Jung-Bin Park, MDPhD  ·  220723664  ·  psb3237@naver.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hee-Soo KimSeoul, Soul-t'ukpyolsi, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07509359